{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:02:15Z","timestamp":1740160935480,"version":"3.37.3"},"reference-count":140,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["FP7-PEOPLE-2012-ITN-315963 (CELLEUROPE)"],"award-info":[{"award-number":["FP7-PEOPLE-2012-ITN-315963 (CELLEUROPE)"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GU0823, 02NUK038A"],"award-info":[{"award-number":["01GU0823, 02NUK038A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB824\/2, DKTK-ROG, Programme Open Access Publishing"],"award-info":[{"award-number":["SFB824\/2, DKTK-ROG, Programme Open Access Publishing"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2016.00660","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T06:13:48Z","timestamp":1484547228000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute\/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.3389","volume":"7","author":[{"given":"Mateja Kralj","family":"Juric","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxim","family":"Shevtsov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Mozes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Ogonek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel E.","family":"Crossland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hildegard T.","family":"Greinix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst","family":"Holler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva M.","family":"Weissinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Multhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,1,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1056\/NEJM199907013410103","article-title":"Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry","volume":"341","author":"Socie","year":"1999","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","article-title":"Chronic graft-versus-host disease","volume":"9","author":"Lee","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"B3","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"389\u2013401","key":"B4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B5","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.bbmt.2015.01.003","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. The 2014 Biomarker Working Group Report","volume":"21","author":"Paczesny","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"issue":"15","key":"B7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1182\/asheducation-2012.1.230","article-title":"Haploidentical transplantation for hematologic malignancies: where do we stand?","volume":"23","author":"Fuchs","year":"2012","journal-title":"Hematolopgy Am Soc Hematol Educ Program"},{"key":"B8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.bbmt.2007.10.009","article-title":"Elevated numbers of immature\/transitional CD21- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease","volume":"14","author":"Greinix","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2014-12-567834","article-title":"Aberrant B-cell homeostasis in chronic GVHD","volume":"125","author":"Sarantopoulos","year":"2015","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1182\/blood-2010-12-322297","article-title":"Chronic GVHD: B cells come of age","volume":"117","author":"Socie","year":"2011","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1182\/blood-2010-07-295766","article-title":"Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia","volume":"117","author":"Kuzmina","year":"2011","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1182\/blood-2008-09-177840","article-title":"Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease","volume":"113","author":"Sarantopoulos","year":"2009","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/(SICI)1096-8652(199606)52:282::AID-AJH33.0.CO;2-1","article-title":"Lack of B cell precursors in marrow transplant recipients with chronic graft-versus-host disease","volume":"52","author":"Storek","year":"1996","journal-title":"Am J Hematol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S0952-7915(02)00332-1","article-title":"BAFFled B cells survive and thrive: roles of BAFF in B-cell development","volume":"14","author":"Rolink","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.1158\/1078-0432.CCR-07-1290","article-title":"High levels of B-cell activating factor in patients with active chronic graft-versus-host disease","volume":"13","author":"Sarantopoulos","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1182\/blood-2012-06-435008","article-title":"CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome","volume":"121","author":"Kuzmina","year":"2013","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1182\/blood-2012-06-438911","article-title":"B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways","volume":"120","author":"Allen","year":"2012","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.bbmt.2014.11.010","article-title":"CD19+CD21low B cells and CD4+CD45RA+CD31+ T cells correlate with first diagnosis of chronic graft-versus-host disease","volume":"21","author":"Greinix","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B19","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1182\/blood-2009-05-221028","article-title":"Proportions of immature CD19+CD21- B lymphocytes predict the response to extracorporeal photopheresis in patients with chronic graft-versus-host disease","volume":"114","author":"Kuzmina","year":"2009","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","first-page":"13451","DOI":"10.1073\/pnas.0901984106","article-title":"Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells","volume":"106","author":"Rakhmanov","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1182\/blood-2009-07-234799","article-title":"Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells","volume":"115","author":"Suryani","year":"2010","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1182\/blood-2014-09-599159","article-title":"CD24(hi)CD27(+) and plasmablast-like regulatory B cells in human chronic graft-versus-host disease","volume":"125","author":"de Masson","year":"2015","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nri2133","article-title":"B-cell anergy: from transgenic models to naturally occurring anergic B cells?","volume":"7","author":"Cambier","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e1016707","DOI":"10.1080\/2162402X.2015.1016707","article-title":"Deficient regulatory B cells in human chronic graft-versus-host disease","volume":"4","author":"de Masson","year":"2015","journal-title":"Oncoimmunology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1182\/blood-2014-04-571125","article-title":"Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD","volume":"124","author":"Khoder","year":"2014","journal-title":"Blood"},{"issue":"22","key":"B26","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","article-title":"IL-2 and regulatory T cells in graft-versus-host disease","volume":"365","author":"Koreth","year":"2011","journal-title":"N Engl J Med"},{"issue":"7","key":"B27","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1182\/blood-2004-03-1040","article-title":"Association of Foxp3 regulatory gene expression with graft-versus-hist disease","volume":"104","author":"Miura","year":"2004","journal-title":"Blood"},{"issue":"8","key":"B28","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1182\/blood-2005-03-1257","article-title":"Reduced frequency of FOXP3+CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease","volume":"106","author":"Zorn","year":"2005","journal-title":"Blood"},{"issue":"5","key":"B29","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1172\/JCI41072","article-title":"Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation","volume":"120","author":"Matsuoka","year":"2010","journal-title":"J Clin Invest"},{"issue":"3","key":"B30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/sj.leu.2404079","article-title":"Increase of CCR7-CD45RA+CD8 T cells (T(EMRA)) in chronic graft-versus-host diesease","volume":"20","author":"D`Asaro","year":"2006","journal-title":"Leukemia"},{"issue":"10","key":"B31","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1182\/blood-2003-09-3286","article-title":"Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells","volume":"103","author":"Yamashita","year":"2004","journal-title":"Blood"},{"key":"B32","first-page":"474","article-title":"Membrane-bound heat shock protein 70 (Hsp70) in acute myeloid leukemia: a tumor specific recognition structure for the cytolytic activity of autologous NK cells","volume":"88","author":"Gehrmann","year":"2003","journal-title":"Haematologica"},{"key":"B33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3109\/02656736.2013.807439","article-title":"Intracellular and extracellular Hsp70 chaperone as a target for cancer therapy","volume":"29","author":"Guzhova","year":"2013","journal-title":"Int J Hyperthermia"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/eji.201040616","article-title":"Stress for maintaining memory: HSP70 as a mobile messenger for innate and adaptive immunity","volume":"40","author":"Chen","year":"2010","journal-title":"Eur J Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1189\/jlb.0109005","article-title":"Heat shock proteins and immune system","volume":"85","author":"Tsan","year":"2009","journal-title":"J Leukoc Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fmolb.2015.00029","article-title":"Multi-layered molecular mechanisms of polypeptide holding, unfolding and disaggregation by HSP70\/HSP110 chaperones","volume":"2","author":"Finka","year":"2015","journal-title":"Front Mol Biosci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.jmb.2015.02.004","article-title":"How hsp70 molecular machines interact with their substrates to mediate diverse physiological functions","volume":"427","author":"Clerico","year":"2015","journal-title":"J Mol Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-3-319-11731-7_12","article-title":"The role of HSP70 and its co-chaperones in protein misfolding, aggregation and disease","volume":"78","author":"Duncan","year":"2015","journal-title":"Subcell Biochem"},{"key":"B39","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.leukres.2007.03.027","article-title":"An Hsp70 peptide initiates NK cell killing of leukemic blasts after stem cell transplantation","volume":"32","author":"Gross","year":"2008","journal-title":"Leuk Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e1925","DOI":"10.1371\/journal.pone.0001925","article-title":"Tumor-specific Hsp70 plasma membrane localization is enabled by the glycosphingolipid Gb3","volume":"3","author":"Gehrmann","year":"2008","journal-title":"PLoS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1158\/0008-5472.CAN-04-3804","article-title":"Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells","volume":"65","author":"Gastpar","year":"2005","journal-title":"Cancer Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2155-9899.1000264","article-title":"Quantitative analysis of liposomal heat shock protein 70 (Hsp70) in the blood of tumor patients using an novel lipHsp70 ELISA","volume":"5","author":"Breuninger","year":"2014","journal-title":"Clin Cell Immunol"},{"key":"B43","first-page":"34","article-title":"Stress proteins and initiation of immune response: chaperokine activity of Hsp72","volume":"11","author":"Asea","year":"2005","journal-title":"Exerc Immunol Rev"},{"key":"B44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fimmu.2016.00171","article-title":"Heat shock protein-peptide and HSP-based immunotherapies for the treatment of Cancer","volume":"7","author":"Shevtsov","year":"2016","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1097\/TP.0b013e31817753f7","article-title":"Correlation of Hsp70-1 and Hsp70-2 gene expression with the degree of graft-versus-host reaction in a rat skin explant model","volume":"85","author":"Novota","year":"2008","journal-title":"Transplantation"},{"key":"B46","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1399-0012.2009.01094.x","article-title":"Patient HSP70-hom TG haplotype is associated with decreased transplant-related mortality and improved survival after sibling HLA-matched hematopoietic stem cell transplantation","volume":"24","author":"Kim","year":"2010","journal-title":"Clin Transplant"},{"key":"B47","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2174\/157488806776956850","article-title":"Non-HLA gene polymorphisms and the outcome of allogeneic hematopoietic stem cell transplantation","volume":"1","author":"Bogunia-Kubik","year":"2006","journal-title":"Curr Stem Cell Res Ther"},{"key":"B48","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/01.TP.0000153157.97736.2C","article-title":"HSP70-hom gene polymorphism in allogeneic hematopoietic stem-cell transplant recipients correlates with the development of acute graft-versus-host disease","volume":"79","author":"Bogunia-Kubik","year":"2005","journal-title":"Transplantation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1006\/clin.1997.4473","article-title":"Expression of 70-kDa heat-shock protein during acute graft-versus-host disease","volume":"86","author":"Goral","year":"1998","journal-title":"Clin Immunol Immunopathol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1006\/clin.1995.1064","article-title":"Antibodies specific for the 70-kDa heat-shock protein parallel the development of acute graft-versus-host disease in (DA x LEW)F1 rats","volume":"75","author":"Goral","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/j.1399-3046.2006.00566.x","article-title":"Antibodies to 60, 65 and 70 kDa heat shock proteins in pediatric allogeneic stem cell transplant recipients","volume":"10","author":"Zlacka","year":"2006","journal-title":"Pediatr Transplant"},{"key":"B52","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1046\/j.1365-2249.2002.01770.x","article-title":"Antibodies to 70 kD and 90 kD heat shock proteins are associated with graft-versus-host disease in peripheral blood stem cell transplant recipients","volume":"127","author":"Goral","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.4049\/jimmunol.168.6.2997","article-title":"Heat shock proteins gp96 and hsp70 activate the release of nitric oxide by APCs","volume":"168","author":"Panjwani","year":"2002","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.4049\/jimmunol.169.5.2422","article-title":"Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70","volume":"169","author":"Wang","year":"2002","journal-title":"J Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e105737","DOI":"10.1371\/journal.pone.0105737","article-title":"Hsp70 regulates immune response in experimental autoimmune encephalomyelitis","volume":"9","author":"Mansilla","year":"2014","journal-title":"PLoS One"},{"key":"B56","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/exd.12183","article-title":"A central role for inducible heat-shock protein 70 in autoimmune vitiligo","volume":"22","author":"Mosenson","year":"2013","journal-title":"Exp Dermatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.4049\/jimmunol.0901288","article-title":"Transgenic expression of Hsc70 in pancreatic islets enhances autoimmune diabetes in response to beta cell damage","volume":"183","author":"Alam","year":"2009","journal-title":"J Immunol"},{"key":"B58","first-page":"1","volume-title":"Heat Shock Proteins in Health and Disease: Therapeutic Targets or Therapeutic Agents? Expert Reviews in Molecular Medicine","author":"Pockley","year":"2001"},{"key":"B59","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1189\/jlb.0607356","article-title":"Sensing danger \u2013 Hsp72 and HMGB1 as candidate signals","volume":"83","author":"Williams","year":"2008","journal-title":"J Leukoc Biol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1002\/eji.200535002","article-title":"Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity","volume":"35","author":"Calderwood","year":"2005","journal-title":"Eur J Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"550","DOI":"10.12659\/AOT.889599","article-title":"Differential expression of heat shock proteins in healthy and diseased human renal allografts","volume":"18","author":"O\u2019Neill","year":"2013","journal-title":"Ann Transplant"},{"key":"B62","first-page":"89","article-title":"Role of heat shock protein 70 in innate alloimmunity","volume":"2","author":"Land","year":"2011","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/01.prs.0000220482.94982.01","article-title":"Induction of heat shock proteins in a rat composite tissue allotransplantation model of acute rejection","volume":"118","author":"Lee","year":"2006","journal-title":"Plast Reconstr Surg"},{"key":"B64","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.trim.2004.08.003","article-title":"Targeted gene disruption of the heat shock protein 72 gene (hsp70.1) in the donor tissue is associated with a prolonged rejection-free survival in the murine skin allograft model","volume":"13","author":"Oh","year":"2004","journal-title":"Transpl Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0171-2985(00)80032-7","article-title":"Reduced levels of Hsp70 result in a therapeutic effect of 15-deoxyspergualin on acute graft-versus-host disease in (DA x LEW)F1 rats","volume":"202","author":"Goral","year":"2000","journal-title":"Immunobiology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1182\/blood-2011-10-387357","article-title":"Plasma biomarkers of lower gastrointestinal and liver acute GVHD","volume":"119","author":"Harris","year":"2012","journal-title":"Blood"},{"key":"B67","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1182\/blood-2012-01-403063","article-title":"Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study","volume":"119","author":"Levine","year":"2012","journal-title":"Blood"},{"key":"B68","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.1182\/blood-2011-08-375006","article-title":"Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease","volume":"118","author":"Ferrara","year":"2011","journal-title":"Blood"},{"key":"B69","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1182\/blood-2008-07-167098","article-title":"A biomarker panel for acute graft-versus-host disease","volume":"113","author":"Paczesny","year":"2009","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.exphem.2006.02.013","article-title":"Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis","volume":"34","author":"Srinivasan","year":"2006","journal-title":"Exp Hematol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.exphem.2006.10.009","article-title":"Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation","volume":"35","author":"Imanguli","year":"2007","journal-title":"Exp Hematol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2352-3026(14)00035-0","article-title":"A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study","volume":"2","author":"Levine","year":"2015","journal-title":"Lancet Haematol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai acute GVHD international consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B74","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1182\/blood-2013-08-520072","article-title":"Plasma CXCL9 elevations correlate with chronic GVHD diagnosis","volume":"123","author":"Kitko","year":"2014","journal-title":"Blood"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1200\/JCO.2015.65.9615","article-title":"Biomarker panel for chronic graft-versus-host disease","volume":"34","author":"Yu","year":"2016","journal-title":"J Clin Oncol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/bmt.2016.125","article-title":"Identification and validation of biomarkers associated with acute and chronic graft versus host disease","volume":"51","author":"Ahmed","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"B77","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/bmt.2013.97","article-title":"Biologic markers of chronic GVHD","volume":"49","author":"Pidala","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1111\/ajt.13750","article-title":"Proteomic characterization reveals that MMP-3 correlates with bronchiolitis obliterans syndrome following allogeneic hematopoietic cell and lung transplantation","volume":"16","author":"Liu","year":"2016","journal-title":"Am J Transplant"},{"key":"B79","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1073\/pnas.1222900110","article-title":"H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs host disease","volume":"110","author":"Sahaf","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1182\/blood-2004-09-3660","article-title":"Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission","volume":"105","author":"Miklos","year":"2005","journal-title":"Blood"},{"key":"B81","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"B83","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1182\/blood-2015-07-657114","article-title":"GvHD and miR: good things in small packages","volume":"126","author":"Serody","year":"2015","journal-title":"Blood"},{"key":"B84","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrm3611","article-title":"Diversifying microRNA sequence and function","volume":"14","author":"Ameres","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e3694","DOI":"10.1371\/journal.pone.0003694","article-title":"Detection of microRNA expression in human peripheral blood microvesicles","volume":"3","author":"Hunter","year":"2008","journal-title":"PLoS One"},{"key":"B86","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.mrfmmm.2011.03.004","article-title":"Extracellular microRNA: a new source of biomarkers","volume":"717","author":"Etheridge","year":"2011","journal-title":"Mutat Res"},{"key":"B87","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat Cell Biol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.1093\/nar\/gkr254","article-title":"Characterization of extracellular circulating microRNA","volume":"39","author":"Turchinovich","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e30679","DOI":"10.1371\/journal.pone.0030679","article-title":"The majority of microRNAs detectable in serum and saliva is concentrated in exosomes","volume":"7","author":"Gallo","year":"2012","journal-title":"PLoS One"},{"key":"B90","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ygyno.2008.04.033","article-title":"MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer","volume":"110","author":"Taylor","year":"2008","journal-title":"Gynecol Oncol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jaut.2009.02.012","article-title":"MicroRNA in autoimmunity and autoimmune diseases","volume":"32","author":"Pauley","year":"2009","journal-title":"J Autoimmun"},{"key":"B92","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1182\/blood-2013-06-510586","article-title":"Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease","volume":"122","author":"Xiao","year":"2013","journal-title":"Blood"},{"key":"B93","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/ctr.12314","article-title":"Serum microRNA155 is increased in patients with acute graft-versus-host disease","volume":"28","author":"Xie","year":"2014","journal-title":"Clin Transplant"},{"issue":"624\u201334","key":"B94","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.exphem.2016.03.005","article-title":"Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation","volume":"44","author":"Gimondi","year":"2016","journal-title":"Exp Hematol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/ajh.24136","article-title":"MicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-gamma production","volume":"90","author":"Sang","year":"2015","journal-title":"Am J Hematol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00277-015-2414-z","article-title":"Plasma microRNA-586 is a new biomarker for acute graft-versus-host disease","volume":"94","author":"Wang","year":"2015","journal-title":"Ann Hematol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"e41561","DOI":"10.1371\/journal.pone.0041561","article-title":"Comparing the microRNA spectrum between serum and plasma","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"B98","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1182\/blood-2011-10-387522","article-title":"Regulation of acute graft-versus-host disease by microRNA-155","volume":"119","author":"Ranganathan","year":"2012","journal-title":"Blood"},{"key":"B99","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1126\/science.1139253","article-title":"Requirement of bic\/microRNA-155 for normal immune function","volume":"316","author":"Rodriguez","year":"2007","journal-title":"Science"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1073\/pnas.0610731104","article-title":"MicroRNA-155 is induced during the macrophage inflammatory response","volume":"104","author":"O\u2019Connell","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1073\/pnas.0811073106","article-title":"MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells","volume":"106","author":"Ceppi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/j.celrep.2012.10.025","article-title":"Epistasis between microRNAs 155 and 146a during T cell-mediated antitumor immunity","volume":"2","author":"Huffaker","year":"2012","journal-title":"Cell Rep"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","article-title":"The microRNA spectrum in 12 body fluids","volume":"56","author":"Weber","year":"2010","journal-title":"Clin Chem"},{"key":"B104","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.4049\/jimmunol.0803162","article-title":"Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells","volume":"182","author":"Kohlhaas","year":"2009","journal-title":"J Immunol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.immuni.2008.11.010","article-title":"Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein","volume":"30","author":"Lu","year":"2009","journal-title":"Immunity"},{"key":"B106","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.immuni.2012.12.006","article-title":"MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer","volume":"38","author":"Dudda","year":"2013","journal-title":"Immunity"},{"key":"B107","doi-asserted-by":"publisher","first-page":"11382","DOI":"10.1073\/pnas.0704853104","article-title":"T cell-specific deletion of the inositol phosphatase SHIP reveals its role in regulating Th1\/Th2 and cytotoxic responses","volume":"104","author":"Tarasenko","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B108","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.clinbiochem.2013.03.015","article-title":"Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: promises and challenges","volume":"46","author":"De Guire","year":"2013","journal-title":"Clin Biochem"},{"key":"B109","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jmoldx.2011.09.002","article-title":"Plasma components affect accuracy of circulating cancer-related microRNA quantitation","volume":"14","author":"Kim","year":"2012","journal-title":"J Mol Diagn"},{"key":"B110","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1373\/clinchem.2010.157198","article-title":"Analysis of circulating microRNA: preanalytical and analytical challenges","volume":"57","author":"McDonald","year":"2011","journal-title":"Clin Chem"},{"key":"B111","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1158\/1940-6207.CAPR-11-0370","article-title":"Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies","volume":"5","author":"Pritchard","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"key":"B112","doi-asserted-by":"publisher","first-page":"e57841","DOI":"10.1371\/journal.pone.0057841","article-title":"Dampening enthusiasm for circulating microRNA in breast cancer","volume":"8","author":"Leidner","year":"2013","journal-title":"PLoS One"},{"key":"B113","doi-asserted-by":"publisher","first-page":"539680","DOI":"10.1155\/2013\/539680","article-title":"Circulating MicroRNAs as biomarkers of prostate cancer: the state of play","volume":"2013","author":"Sapre","year":"2013","journal-title":"Prostate Cancer"},{"key":"B114","doi-asserted-by":"publisher","first-page":"14785","DOI":"10.3390\/ijms140714785","article-title":"Extracellular microRNAs in urologic malignancies: chances and challenges","volume":"14","author":"Huang","year":"2013","journal-title":"Int J Mol Sci"},{"key":"B115","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/nmeth.3014","article-title":"Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study","volume":"11","author":"Mestdagh","year":"2014","journal-title":"Nat Methods"},{"key":"B116","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1182\/blood-2004-02-0518","article-title":"Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation","volume":"104","author":"Kaiser","year":"2004","journal-title":"Blood"},{"key":"B117","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.1182\/blood-2007-01-069757","article-title":"Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"109","author":"Weissinger","year":"2007","journal-title":"Blood"},{"key":"B118","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/leu.2013.210","article-title":"Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation","volume":"28","author":"Weissinger","year":"2014","journal-title":"Leukemia"},{"key":"B119","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2174\/138955709788167583","article-title":"Proteome analysis in hematology using capillary electrophoresis coupled on-line to mass spectrometry","volume":"9","author":"Weissinger","year":"2009","journal-title":"Mini Rev Med Chem"},{"key":"B120","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/978-1-59745-223-6_15","article-title":"Application of proteomics to posttransplantational follow-up","volume":"134","author":"Weissinger","year":"2007","journal-title":"Methods Mol Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1586\/14789450.2.5.639","article-title":"Online coupling of capillary electrophoresis with mass spectrometry for the identification of biomarkers for clinical diagnosis","volume":"2","author":"Weissinger","year":"2005","journal-title":"Expert Rev Proteomics"},{"key":"B122","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00277-005-0057-1","article-title":"Value of proteomics applied to the follow-up in stem cell transplantation","volume":"85","author":"Weissinger","year":"2006","journal-title":"Ann Hematol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-0-387-78580-6_5","article-title":"Immunogenomics and proteomics in hematopoietic stem cell transplantation: predicting post-hematopoietic stem cell transplant complications","volume":"144","author":"Weissinger","year":"2009","journal-title":"Cancer Treat Res"},{"key":"B124","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bbmt.2006.01.008","article-title":"Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response criteria working group report","volume":"12","author":"Pavletic","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"B125","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1182\/blood-2012-04-424135","article-title":"Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium","volume":"120","author":"Jacobsohn","year":"2012","journal-title":"Blood"},{"issue":"Suppl 1","key":"B126","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1097\/01.cco.0000357475.66035.d2","article-title":"Pathophysiology and management of graft-versus-host disease in the era of reduced-intensity conditioning","volume":"21","author":"Landfried","year":"2009","journal-title":"Curr Opin Oncol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.2174\/138161209788453158","article-title":"Pharmaceutical and cellular strategies in prophylaxis and treatment of graft-versus-host disease","volume":"15","author":"Wolff","year":"2009","journal-title":"Curr Pharm Des"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.bbmt.2010.06.015","article-title":"Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD","volume":"16","author":"Wolff","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"B129","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/978-1-59745-409-4_29","article-title":"Proteomics studies after hematopoietic stem cell transplantation","volume":"506","author":"Weissinger","year":"2009","journal-title":"Methods Mol Biol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1182\/blood-2015-12-688895","article-title":"Circulating T follicular helper cells with increased function during chronic graft-versus-host disease","volume":"127","author":"Forcade","year":"2016","journal-title":"Blood"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.bbmt.2015.04.016","article-title":"Intestinal Blautia is associated with reduced death from graft-versus-host disease","volume":"21","author":"Jenq","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B132","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.beha.2015.10.013","article-title":"Role of intestinal microbiota in transplantation outcomes","volume":"28","author":"Taur","year":"2015","journal-title":"Best Pract Res Clin Haematol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.bbmt.2014.01.030","article-title":"Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease","volume":"20","author":"Holler","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1182\/blood-2014-02-554725","article-title":"The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation","volume":"124","author":"Taur","year":"2014","journal-title":"Blood"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1182\/blood-2015-04-638858","article-title":"Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome","volume":"126","author":"Weber","year":"2015","journal-title":"Blood"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1182\/blood-2014-10-609032","article-title":"Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation","volume":"125","author":"Holtan","year":"2015","journal-title":"Blood"},{"key":"B137","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.1182\/blood-2011-12-397968","article-title":"Fecal calprotectin and alpha-1 antitrypsin predict severity and response to corticosteroids in gastrointestinal graft-versus-host disease","volume":"119","author":"Rodriguez-Otero","year":"2012","journal-title":"Blood"},{"key":"B138","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00277-013-1957-0","article-title":"Serum albumin level predicts survival of patients with gastrointestinal acute graft-versus-host disease after allogeneic stem cell transplantation","volume":"93","author":"Ayuk","year":"2014","journal-title":"Ann Hematol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.bbmt.2011.07.021","article-title":"Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation","volume":"17","author":"Rezvani","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"B140","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.bbmt.2015.01.001","article-title":"A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality","volume":"21","author":"MacMillan","year":"2015","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2016.00660\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T06:13:53Z","timestamp":1484547233000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2016.00660\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,16]]},"references-count":140,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2016.00660","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2017,1,16]]}}}